Posts tagged White Oak
38 | Vigil: A Safety Framework for Psychedelic Care
38 | Vigil: A Safety Framework for Psychedelic Care

Somewhere tonight a person is taking a psychedelic with no one awake beside them. A five-part safety standard written for the FDA, drug developers, state regulators, clinics and guides, for every room a drug company's rules will never reach.

Read More
Psychedelic PathYeshua AdonaiU.S. Food and Drug AdministrationFDA psychedelic hearing, FDA public hearing 2026, psilocybin, MDMA-assisted therapy, ketamine clinics, REMS, psychedelic policy, docket FDA-2026-N-7542, harm reduction, psychedelic integration, spiritual care, chaplaincy, veterans healing, Oregon psilocybin, White Oak, mast year, Long Now, Arizona
37 | FDA public hearing: The Day the Sacred Was Ruled “Out of Scope”
37 | FDA public hearing: The Day the Sacred Was Ruled “Out of Scope”

On 14 September 02026, the FDA held its first public hearing on psychedelic drugs as a class and ruled religious, ceremonial, and personal use out of scope. Eighty speakers, two minutes each, not one question. A letter on the gap the Notice left open.

Read More
Psychedelic PathYeshua AdonaiU.S. Food and Drug AdministrationFDA psychedelic hearing, FDA public hearing 2026, psilocybin, MDMA-assisted therapy, ketamine clinics, REMS, psychedelic policy, docket FDA-2026-N-7542, harm reduction, psychedelic integration, spiritual care, chaplaincy, veterans healing, Oregon psilocybin, White Oak, mast year, Long Now, Arizona